BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38134241)

  • 21. CARD8 is a negative regulator for NLRP3 inflammasome, but mutant NLRP3 in cryopyrin-associated periodic syndromes escapes the restriction.
    Ito S; Hara Y; Kubota T
    Arthritis Res Ther; 2014 Feb; 16(1):R52. PubMed ID: 24517500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Mechanosensitive Ion Channel PIEZO1 in Intestinal Epithelial Cells Mediates Inflammation through the NOD-Like Receptor 3 Pathway in Crohn's Disease.
    Liu Q; Wang D; Yang X; Ma F; Han W; Hu J; Mei Q
    Inflamm Bowel Dis; 2023 Jan; 29(1):103-115. PubMed ID: 35907203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-frequency mosaicism in cryopyrin-associated periodic fever syndrome: mosaicism in systemic autoinflammatory diseases.
    Nishikomori R; Izawa K; Kambe N; Ohara O; Yasumi T
    Int Immunol; 2019 Sep; 31(10):649-655. PubMed ID: 31185077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HSP90β controls NLRP3 autoactivation.
    Spel L; Hou C; Theodoropoulou K; Zaffalon L; Wang Z; Bertoni A; Volpi S; Hofer M; Gattorno M; Martinon F
    Sci Adv; 2024 Mar; 10(9):eadj6289. PubMed ID: 38416826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered Pigs Carrying a Gain-of-Function NLRP3 Homozygous Mutation Can Survive to Adulthood and Accurately Recapitulate Human Systemic Spontaneous Inflammatory Responses.
    Li W; Shi L; Zhuang Z; Wu H; Lian M; Chen Y; Li L; Ge W; Jin Q; Zhang Q; Zhao Y; Liu Z; Ouyang Z; Ye Y; Li Y; Wang H; Liao Y; Quan L; Xiao L; Lai L; Meng G; Wang K
    J Immunol; 2020 Nov; 205(9):2532-2544. PubMed ID: 32958688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational Modeling of NLRP3 Identifies Enhanced ATP Binding and Multimerization in Cryopyrin-Associated Periodic Syndromes.
    Samson JM; Ravindran Menon D; Vaddi PK; Kalani Williams N; Domenico J; Zhai Z; Backos DS; Fujita M
    Front Immunol; 2020; 11():584364. PubMed ID: 33329557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel Nlrp3 knock-in mouse model with hyperactive inflammasome in development of lethal inflammation.
    Zhou Y; Yang X; Zhu L
    Clin Exp Immunol; 2024 Feb; 215(2):202-214. PubMed ID: 37594231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cold-induced loss of interaction with HSC70 triggers inflammasome activity of familial cold autoinflammatory syndrome-causing mutants of NLRP3.
    Raghawan AK; Ramaswamy R; Swarup G
    Biochem Biophys Res Commun; 2023 Jan; 641():42-49. PubMed ID: 36521284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.
    Brydges SD; Broderick L; McGeough MD; Pena CA; Mueller JL; Hoffman HM
    J Clin Invest; 2013 Nov; 123(11):4695-705. PubMed ID: 24084736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
    Liu X; Pichulik T; Wolz OO; Dang TM; Stutz A; Dillen C; Delmiro Garcia M; Kraus H; Dickhöfer S; Daiber E; Münzenmayer L; Wahl S; Rieber N; Kümmerle-Deschner J; Yazdi A; Franz-Wachtel M; Macek B; Radsak M; Vogel S; Schulte B; Walz JS; Hartl D; Latz E; Stilgenbauer S; Grimbacher B; Miller L; Brunner C; Wolz C; Weber ANR
    J Allergy Clin Immunol; 2017 Oct; 140(4):1054-1067.e10. PubMed ID: 28216434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The discovery of NLRP3 and its function in cryopyrin-associated periodic syndromes and innate immunity.
    Putnam CD; Broderick L; Hoffman HM
    Immunol Rev; 2024 Mar; 322(1):259-282. PubMed ID: 38146057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome.
    Hu J; Zhu Y; Zhang JZ; Zhang RG; Li HM
    Chin Med J (Engl); 2017 Mar; 130(5):586-593. PubMed ID: 28229991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation.
    Xu Z; Chen ZM; Wu X; Zhang L; Cao Y; Zhou P
    Front Immunol; 2020; 11():609441. PubMed ID: 33424864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of Myeloid-Derived Suppressor Cells in Cryopyrin-Associated Periodic Syndromes.
    Ballbach M; Hall T; Brand A; Neri D; Singh A; Schaefer I; Herrmann E; Hansmann S; Handgretinger R; Kuemmerle-Deschner J; Hartl D; Rieber N
    J Innate Immun; 2016; 8(5):493-506. PubMed ID: 27351923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetics of cryopyrin-associated periodic syndrome].
    Kümmerle-Deschner JB; Lohse P
    Z Rheumatol; 2017 May; 76(4):313-321. PubMed ID: 28197772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
    Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A; Henry C; Jones GS; Goodrich SA; St Laurent JP; Jones TM; Scribner CL; Barrow RB; Altman RD; Skouras DB; Gattorno M; Grau V; Janciauskiene S; Rubartelli A; Joosten LAB; Dinarello CA
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1530-E1539. PubMed ID: 29378952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FAAH served a key membrane-anchoring and stabilizing role for NLRP3 protein independently of the endocannabinoid system.
    Zhu Y; Zhang H; Mao H; Zhong S; Huang Y; Chen S; Yan K; Zhao Z; Hao X; Zhang Y; Yao H; Huang X; Wang M; Zhang W; Li J; Meng G; Qin X; Ye Z; Shen J; Song Y; Xu Y; Yang Z; Wang L; Zhang Y; Wen L
    Cell Death Differ; 2023 Jan; 30(1):168-183. PubMed ID: 36104448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors.
    Bertoni A; Carta S; Baldovini C; Penco F; Balza E; Borghini S; Di Duca M; Ognio E; Signori A; Nozza P; Schena F; Castellani P; Pastorino C; Perrone C; Obici L; Martini A; Ceccherini I; Gattorno M; Rubartelli A; Chiesa S
    J Allergy Clin Immunol; 2020 Jan; 145(1):368-378.e13. PubMed ID: 31194989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
    Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
    Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation.
    Tang T; Lang X; Xu C; Wang X; Gong T; Yang Y; Cui J; Bai L; Wang J; Jiang W; Zhou R
    Nat Commun; 2017 Aug; 8(1):202. PubMed ID: 28779175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.